A prospective study of aspirin use and prostate cancer risk by TMPRSS2:ERG status

BACKGROUND: In a case-control study, aspirin use was associated with a lower risk of a common prostate cancer molecular subtype, the TMPRSS2:ERG gene fusion. We sought to validate this finding in a prospective cohort. METHODS: In the Health Professionals Follow-up Study, 49,395 men reported on aspir...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Epidemiol Biomarkers Prev
Main Authors: Stopsack, Konrad H., Gonzalez-Feliciano, Amparo G., Peisch, Samuel F., Downer, Mary K., Gage, Riley A., Finn, Stephen, Lis, Rosina T., Graff, Rebecca E., Pettersson, Andreas, Pernar, Claire H., Loda, Massimo, Kantoff, Philip W., Ahearn, Thomas U., Mucci, Lorelei A.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6170677/
https://ncbi.nlm.nih.gov/pubmed/30108097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-18-0510
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki